Who is sponsoring NCT05789550?

NCT05789550 is sponsored by Assiut University.

What drugs are being tested in NCT05789550?

Interventions in NCT05789550: ALL PATIENT DIABETIC IN THIS PERIOD WILL BE INCLUDED IN THE STUDY.

What condition does NCT05789550 study?

NCT05789550 studies H Pylori Infection.

Is NCT05789550 still recruiting?

NCT05789550 is currently status unknown. Last updated 29 March 2023.

Last reviewed 2023-03-29 · How we verify

NCT05789550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HELICOBACTER PYLORI INFECTION IN TYPE 2 DIABETES MELLITUS IN ASSIUT UNIVERSITY HOSPITAL

Status unknown Last updated 29 March 2023

What this trial tests

trial testing ALL PATIENT DIABETIC IN THIS PERIOD WILL BE INCLUDED IN THE STUDY in H Pylori Infection in 146 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
1 May 2024

1 June 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	146
Start date	1 April 2023
Primary completion	1 May 2024
Estimated completion	1 June 2024

Drugs / interventions tested

ALL PATIENT DIABETIC IN THIS PERIOD WILL BE INCLUDED IN THE STUDY

Conditions studied

H Pylori Infection — all drugs for H Pylori Infection →

Sponsor

Assiut University

Who can join

Adults 35 to 75, any sex, with H Pylori Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to study the association of H. pylori infection with T2DM and its relation with glycated hemoglobin (HbA1c) levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for H Pylori Infection

Currently open trials in the same condition.

NCT07179237 — Efficacy of Carminal in Helicobacter Pylori Gastritis · Phase 2 · recruiting
NCT06275204 — H. Pylori Screen-and-treat Study in a Population of Young Adults · recruiting
NCT07224035 — Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 · Phase 4 · active not recruiting
NCT06579365 — Argentinean Registry on the Management of Helicobacter Pylori Infection · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05789550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05789550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing